Latest

Anti-obesity agents

New Research on Liver Diseases and Conditions Reveals Promise of Glucagon-Like Peptide-1 Receptor Agonists

Investigators at Rutgers University - The State University of New Jersey have conducted new research on liver diseases and conditions, highlighting the potential of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in managing metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The study, published in Clinics

Diabetes therapy

Nurse-Led Interventions Improve Self-Management Behaviours and Self-Efficacy in Individuals with Type 2 Diabetes

A systematic review and meta-analysis conducted by researchers from Beihua University found that nurse-led interventions significantly improved self-management behaviours and self-efficacy in individuals with type 2 diabetes mellitus. The study, published in the International Journal of Nursing Practice, aimed to evaluate the effectiveness of nurse-led self-management interventions on self-management behaviours